AI Stock Finder
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

CLYM vs FTH: stock comparison and AI forecast

Climb Bio, Inc. (CLYM) and Faeth Therapeutics, Inc. (FTH) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

CLYM Climb Bio, Inc.

Market Cap
$509M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

FTH Faeth Therapeutics, Inc.

Price
$19.92 -16.2% · 6M
Market Cap
$515M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

CLYM · FTH

Key facts

  • CLYM and FTH have similar market capitalizations ($509M and $515M).
  • FTH carries 0.07 times debt per unit of equity, against 0.04 times for CLYM.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricCLYMFTH
Market Cap$509M$515M
P/B Ratio2.23x3.20x
EPS$-0.87$-58.08
Book Value/Share$3.97$6.23
FCF/Share–$-1.67

Profitability & Margins

MetricCLYMFTH
ROE-26.0%–
ROA-25.1%–
ROIC-29.2%-128.7%
Tax Rate0.0%0.0%

Financial Health

MetricCLYMFTH
Current Ratio26.58x16.12x
D/E Ratio0.04x0.07x
Financial Leverage1.04x1.11x
Interest Coverage–-1652.3x
Working Capital$202M$167M

Cash Flow

MetricCLYMFTH
Operating Cash Flow-$53M-$43M
Free Cash Flow–-$43M
Capital Spending–-$10K

Income Statement

MetricCLYMFTH
Operating Income-$67M-$216M
Net Income-$59M–
R&D Expense$44M–

Dividend & Shareholder Information

MetricCLYMFTH
Shares Outstanding57M26M
EPS Growth-495.4%–
FAQ

CLYM vs FTH: stock comparison and AI forecast

Which is bigger, CLYM or FTH?

CLYM and FTH have similar market capitalizations ($509M and $515M).

Which one does Intratio's AI model rank higher, CLYM or FTH?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.